J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 537, Number 3, 779-792, December 12, 2001 DOI: 10.1113/jphysiol.2001.013012
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belevych, A. E.
Right arrow Articles by Harvey, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belevych, A. E.
Right arrow Articles by Harvey, R. D.
Journal of Physiology (2001), 537.3, pp. 779-792
© Copyright 2001 The Physiological Society

Role of tyrosine kinase activity in alpha-adrenergic inhibition of the beta-adrenergically regulated L-type Ca2+ current in guinea-pig ventricular myocytes


Andriy E. Belevych, Amy Nulton-Persson, Carl Sims and Robert D. Harvey


Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, USA

  1. The purpose of this study was to investigate the hypothesis that tyrosine kinase activity contributes to alpha1-adrenergic inhibition of beta-adrenergic responses in cardiac myocytes. We addressed this question by studying the pharmacological regulation of the L-type Ca2+ current in acutely isolated adult guinea-pig ventricular myocytes using the whole-cell patch-clamp technique.
  2. The selective alpha1-adrenergic receptor agonist methoxamine had no effect on the basal L-type Ca2+ current. Methoxamine also had no effect on cAMP-dependent stimulation of the Ca2+ current mediated by H2 histamine receptor activation. However, methoxamine did inhibit cAMP-dependent stimulation of the Ca2+ current mediated by beta-adrenergic receptor activation. The ability of methoxamine to inhibit beta-adrenergic regulation of the Ca2+ current was significantly antagonized by the tyrosine kinase inhibitors genistein and lavendustin A.
  3. The inhibitory effect of methoxamine was also mimicked by the phosphotyrosine phosphatase inhibitor pervanadate (PVN). PVN had no effect on basal Ca2+ current or Ca2+ current stimulated by histamine, but it did inhibit Ca2+ current stimulated by beta-adrenergic receptor activation. Furthermore, the ability of PVN to inhibit beta-adrenergic stimulation of the Ca2+ current was antagonized by lavendustin A.
  4. These results are consistent with the conclusion that in guinea-pig ventricular myocytes alpha-adrenergic inhibition of beta-adrenergic responses involves a tyrosine kinase-dependent signalling pathway. The fact that methoxamine and PVN antagonized cAMP-dependent responses mediated by beta-adrenergic, but not H2 histamine, receptor activation suggests that the inhibitory effect of alpha-adrenergic stimulation and tyrosine kinase activity is at the level of the beta-adrenergic receptor.



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. E. Belevych, S. Warrier, and R. D. Harvey
Genistein Inhibits Cardiac L-Type Ca2+ Channel Activity by a Tyrosine Kinase-Independent Mechanism
Mol. Pharmacol., September 1, 2002; 62(3): 554 - 565.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 The Physiological Society.